Cargando…
Engineering the yeast Yarrowia lipolytica for the production of therapeutic proteins homogeneously glycosylated with Man(8)GlcNAc(2) and Man(5)GlcNAc(2)
BACKGROUND: Protein-based therapeutics represent the fastest growing class of compounds in the pharmaceutical industry. This has created an increasing demand for powerful expression systems. Yeast systems are widely used, convenient and cost-effective. Yarrowia lipolytica is a suitable host that is...
Autores principales: | De Pourcq, Karen, Vervecken, Wouter, Dewerte, Isabelle, Valevska, Albena, Van Hecke, Annelies, Callewaert, Nico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512530/ https://www.ncbi.nlm.nih.gov/pubmed/22548968 http://dx.doi.org/10.1186/1475-2859-11-53 |
Ejemplares similares
-
Engineering Yarrowia lipolytica to Produce Glycoproteins Homogeneously Modified with the Universal Man(3)GlcNAc(2) N-Glycan Core
por: De Pourcq, Karen, et al.
Publicado: (2012) -
Engineering O-glycosylation in modified N-linked oligosaccharide (Man(12)GlcNAc(2)∼Man(16)GlcNAc(2)) Pichia pastoris strains
por: Li, Siqiang, et al.
Publicado: (2019) -
Proteolysis of HCF-1 by Ser/Thr glycosylation-incompetent O-GlcNAc transferase:UDP-GlcNAc complexes
por: Kapuria, Vaibhav, et al.
Publicado: (2016) -
X-inactivation normalizes O-GlcNAc transferase levels and generates an O-GlcNAc-depleted Barr body
por: Olivier-Van Stichelen, Stéphanie, et al.
Publicado: (2014) -
Feedback Regulation of O-GlcNAc Transferase through Translation Control to Maintain Intracellular O-GlcNAc Homeostasis
por: Lin, Chia-Hung, et al.
Publicado: (2021)